Published 6 issues per year
ISSN Print: 1045-4403
ISSN Online: 2162-6502
Indexed in
Current State of Immunosuppression: Past, Present, and Future
ABSTRACT
The success of solid-organ transplantation was made possible by recognizing that destruction of the graft is caused by an alloimmune-mediated process. For the past decade, immunosuppressive protocols have used a combination of drugs that significantly decreased the rate of acute organ rejection. Despite advances in surgical and medical care of recipients of solid-organ transplants, long-term graft survival and patient survival have not improved during the past 2 decades. Current immunosuppression protocols include a combination of calcineurin inhibitors, such as tacrolimus, and antiproliferative agents (most commonly mycophenolate mofetil), with or without different dosing regimens of corticosteroids. Mammalian target of rapamycin inhibitors were introduced to be used in combination with cyclosporine-based therapy, but they did not gain much acceptance because of their adverse event profile. Belatacept, a costimulatory inhibitor, is currently being studied in different regimens in an effort to replace the use of calcineurin inhibitors to induce tolerance and to improve long-term outcomes. Induction therapy is now being used in more than 90% of kidney transplants and more than 50% cases of other solid-organ transplantation such as lung, heart, and intestinal transplants. As a result of these combination immunosuppressive (IS) therapy protocols, not only the incidence but also the intensity of episodes of acute rejection have decreased markedly, and at present 1-year graft and patient survival is almost 98% for kidney transplant recipients and approximately greater than 80% for heart and lung transplants. Evolving concepts include the use of donor-derived bone marrow mesenchymal cells to induce tolerance, to minimize the use of maintenance IS agents, and to prevent the development of adverse events associated with long-term use of maintenance IS therapy.
-
La Muraglia G.M., O'Neil M.J., Madariaga M.L., Michel S.G., Mordecai K.S., Allan J.S., Madsen J.C., Hanekamp I.M., Preffer F.I., A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometry, Journal of Immunological Methods, 427, 2015. Crossref
-
Rancic Nemanja, Dragojevic-Simic Viktorija, Vavic Neven, Kovacevic Aleksandra, Segrt Zoran, Djordjevic Natasa, Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature, Frontiers in Public Health, 4, 2016. Crossref
-
Haidar G., Crespo M., Maximous S., Lendermon E., Clancy C.J., Nguyen M.H., Invasive Tracheobronchial Aspergillosis in a Lung Transplant Recipient Receiving Belatacept as Salvage Maintenance Immunosuppression: A Case Report, Transplantation Proceedings, 48, 1, 2016. Crossref
-
Sá Helena, Leal Rita, Rosa Manuel Santos, Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement, International Reviews of Immunology, 36, 3, 2017. Crossref
-
Kurzawski Mateusz, Malinowski Damian, Dziewanowski Krzysztof, Droździk Marek, Analysis of common polymorphisms within NR1I2 and NR1I3 genes and tacrolimus dose-adjusted concentration in stable kidney transplant recipients, Pharmacogenetics and Genomics, 27, 10, 2017. Crossref
-
Tan Loh Teng-Hern, Chan Kok-Gan, Khan Tahir Mehmood, Bukhari Sarah Ibrahim, Saokaew Surasak, Duangjai Acharaporn, Pusparajah Priyia, Lee Learn-Han, Goh Bey-Hing, Streptomyces sp. MUM212 as a Source of Antioxidants with Radical Scavenging and Metal Chelating Properties, Frontiers in Pharmacology, 8, 2017. Crossref
-
Rancic Nemanja, Vavic Neven, Obrencevic Katarina, Pilipovic Filip, Dragojevic-Simic Viktorija, Tacrolimus Utilization and Expenditure in Serbia, Frontiers in Public Health, 5, 2017. Crossref
-
Holt Curtis D., Overview of Immunosuppressive Therapy in Solid Organ Transplantation, Anesthesiology Clinics, 35, 3, 2017. Crossref
-
Koo Jamie, Wang Hanlin L., Acute, Chronic, and Humoral Rejection, Surgical Pathology Clinics, 11, 2, 2018. Crossref
-
Wong Grace Lai-Hung, Yuen Becky Wing-Yan, Chan Henry Lik-Yuen, Tse Yee-Kit, Yip Terry Cheuk-Fung, Lam Kelvin Long-Yan, Lui Grace Chung-Yan, Wong Vincent Wai-Sun, Negro Francesco, Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B, Liver International, 39, 2, 2019. Crossref
-
Salman J., Jansson K., Siemeni Th., Sommer W., Knoefel A.-K., Ahrens L., Nakagiri T., Ius F., Tudorache I., Kruse B., Thissen S., Jonigk D., Strüber M., Haverich A., Warnecke G., Avsar M., Role for primary immunosuppression with everolimus after pulmonary transplantation, Transplant Immunology, 49, 2018. Crossref
-
Aziz Fahad, Garg Neetika, Parajuli Sandesh, Djamali Arjang, Stein James H., Mandelbrot Didier, Lipid lowering in dialysis patients with cardiovascular disease who are awaiting kidney transplantation, Clinical Transplantation, 2018. Crossref
-
Chang Jessica B., Rifkin William J., Soares Marc A., Duckworth April, Rao Nakul, Low Yee Cheng, Massie Jonathan P., Rabbani Piul S., Saadeh Pierre B., Ceradini Daniel J., Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival, Plastic and Reconstructive Surgery - Global Open, 6, 6, 2018. Crossref
-
Rottembourg Jacques, Rostoker Guy, L’utilisation de génériques en transplantation : vers des solutions rationnelles et sures !, La Presse Médicale, 47, 3, 2018. Crossref
-
Zhao Zhi-Qing, Treatment with dietary cyclosporine has no direct effect on myocardial fibrosis and hypertension in mice, MOJ Drug Design Development & Therapy, 1, 3, 2017. Crossref
-
Kitamura Mineaki, Mochizuki Yasushi, Miyata Yasuyoshi, Obata Yoko, Mitsunari Kensuke, Matsuo Tomohiro, Ohba Kojiro, Mukae Hiroshi, Yoshimura Atsutoshi, Nishino Tomoya, Sakai Hideki, Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation, International Journal of Molecular Sciences, 20, 14, 2019. Crossref
-
Modo Michel, Bioscaffold-Induced Brain Tissue Regeneration, Frontiers in Neuroscience, 13, 2019. Crossref
-
Wong Grace Lai-Hung, Wong Vincent Wai-Sun, Yuen Becky Wing-Yan, Tse Yee-Kit, Yip Terry Cheuk-Fung, Luk Hester Wing-Sum, Lui Grace Chung-Yan, Chan Henry Lik-Yuen, Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure, Journal of Hepatology, 72, 1, 2020. Crossref
-
Houben Rudolph H., Aleff Ross A., Friedrich Patricia F., Shin Alexander Y., Wieben Eric D., van Wijnen Andre J., Bishop Allen T., Transplant chimerism in porcine structural vascularized bone allotransplants, Gene, 747, 2020. Crossref
-
Li Jinpeng, Gao Rongfen, Wu Gaosong, Wu Xiaolin, Liu Zeming, Wang Hongjing, Huang Yihui, Pan Zhenyu, Chen Jincao, Wu Xiaohui, Clinical characteristics of emergency surgery patients infected with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan, China, Surgery, 168, 3, 2020. Crossref
-
Resch Thomas, Cardini Benno, Oberhuber Rupert, Weissenbacher Annemarie, Dumfarth Julia, Krapf Christoph, Boesmueller Claudia, Oefner Dietmar, Grimm Michael, Schneeberger Sefan, Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring, Frontiers in Immunology, 11, 2020. Crossref
-
Cao Peng, Sun Zejia, Feng Chang, Zhang Jiandong, Zhang Feilong, Wang Wei, Zhao Yong, Myeloid-derived suppressor cells in transplantation tolerance induction, International Immunopharmacology, 83, 2020. Crossref
-
Tron Camille, Coste Gwendal, Lalanne Sébastien, Bernard Aurélie, Jan Yann-Gaël, Ferrand-Sorre Marie-José, Verdier Marie-Clémence, Bellissant Eric, Lemaitre Florian, A simple and fast liquid chromatography tandem mass spectrometry method to determine cyclosporine A concentrations in endomyocardial biopsies, Journal of Pharmaceutical and Biomedical Analysis, 193, 2021. Crossref
-
Chen Yi-Wen, Wei Jeng, Chen Hwei-Ling, Cheng Ching-Hui, Hou I-Ching, Developing a Heart Transplantation Self-Management Support Mobile Health App in Taiwan: Qualitative Study, JMIR mHealth and uHealth, 8, 8, 2020. Crossref
-
Ballardin Bárbara Soldatelli, Mobile Rafael Zancan, Torres‐Pereira Cassius Carvalho, Schussel Juliana Lucena, Medication‐related fibrovascular hyperplasia lesion in tongue: Case report, Special Care in Dentistry, 40, 5, 2020. Crossref
-
Chen Bing, Lu Jia-Qian, Shao Kun, Zhai Xiao-Hui, An Hui-Min, Shi Hao-Qiang, Zhou Pei-Jun, Establishment of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Immunosuppressant Levels in the Peripheral Blood Mononuclear Cells of Chinese Renal Transplant Recipients, Therapeutic Drug Monitoring, 42, 5, 2020. Crossref
-
Iglesias Marcos, Khalifian Saami, Oh Byoung C., Zhang Yichuan, Miller Devin, Beck Sarah, Brandacher Gerald, Raimondi Giorgio, A short course of tofacitinib sustains the immunoregulatory effect of CTLA4‐Ig in the presence of inflammatory cytokines and promotes long‐term survival of murine cardiac allografts, American Journal of Transplantation, 21, 8, 2021. Crossref
-
Lúcio Maria João, Horta Ricardo, Hand Transplantation—Risks and Benefits, Journal of Hand and Microsurgery, 13, 04, 2021. Crossref
-
Podestà Manuel Alfredo, Remuzzi Giuseppe, Casiraghi Federica, Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation, Frontiers in Immunology, 11, 2021. Crossref
-
Zhao Lingfei, Hu Chenxia, Han Fei, Chen Dajin, Cheng Jun, Wu Jianyong, Peng Wenhan, Chen Jianghua, Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis, Stem Cell Research & Therapy, 12, 1, 2021. Crossref
-
Ballardin Bárbara Soldatelli, Mobile Rafael Zancan, Coracin Fábio Luiz, Ribeiro Lisandro Lima, Bonfim Carmem Maria Sales, Schussel Juliana Lucena, Torres‐Pereira Cassius, A case series of medication‐related fibrovascular hyperplasia following hematopoietic stem cell transplantation for Fanconi anemia, Pediatric Transplantation, 25, 6, 2021. Crossref
-
Sahman Majda, Mugosa Snezana, Rancic Nemanja, Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study, Frontiers in Public Health, 9, 2021. Crossref
-
Pacheco Mariana P, Carneiro-D'Albuquerque Luiz Augusto, Mazo Daniel F, Current aspects of renal dysfunction after liver transplantation, World Journal of Hepatology, 14, 1, 2022. Crossref
-
Yip Terry Cheuk-Fung, Gill Madeleine, Wong Grace Lai-Hung, Liu Ken, Management of hepatitis B virus reactivation due to treatment of COVID-19, Hepatology International, 16, 2, 2022. Crossref
-
Overvad Maria, Koch Anders, Jespersen Bente, Gustafsson Finn, Krause Tyra Grove, Hansen Christian Holm, Ethelberg Steen, Obel Niels, Outcomes following SARS‐CoV ‐2 infection in individuals with and without solid organ transplantation—A Danish nationwide cohort study , American Journal of Transplantation, 2022. Crossref